FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (141 ms)

Package us.nlm.vsac
Type ValueSet
Id Id
FHIR Version R4
Source http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1235.231/expansion
Url http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.231
Version 20230118
Status active
Date 2023-01-18T01:03:05-05:00
Name InfluenzaVaccineCN_HD_CPT
Title Influenza Vaccine CN_HD_CPT
Experimental False
Realm us
Authority hl7
Description b.well created value set by Sr. Clinical Business Analyst for Influenza Vaccine - Adult Care Need.
Purpose (Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute Influenza Vaccine - Adult Care Need for inclusion and utilization in patients/users connected heath.),(Data Element Scope: Influenza Vaccine - Adult Care Need for b.well.),(Inclusion Criteria: Codes that constitute the Flu Vaccine - Adult & Influenza Vaccine - Adult Care Need for b.well.),(Exclusion Criteria: N/A)

Resources that use this resource

ValueSet
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.232 Influenza Vaccine_HD_CN_Grouping

Resources that this resource uses

CodeSystem
http://www.ama-assn.org/go/cpt Current Procedural Terminology (CPT®)
http://www.ama-assn.org/go/cpt Current Procedural Terminology (CPT®)

Source

{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1235.231",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "B.well Connected Health Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-06-04"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2023-01-18"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.231",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1235.231"
    }
  ],
  "version" : "20230118",
  "name" : "InfluenzaVaccineCN_HD_CPT",
  "title" : "Influenza Vaccine CN_HD_CPT",
  "status" : "active",
  "date" : "2023-01-18T01:03:05-05:00",
  "publisher" : "B.well Connected Health Steward",
  "description" : "b.well created value set by Sr. Clinical Business Analyst for Influenza Vaccine - Adult Care Need.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute Influenza Vaccine - Adult Care Need for inclusion and utilization in patients/users connected heath.),(Data Element Scope: Influenza Vaccine - Adult Care Need for b.well.),(Inclusion Criteria: Codes that constitute the Flu Vaccine - Adult & Influenza Vaccine - Adult Care Need for b.well.),(Exclusion Criteria: N/A)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "concept" : [
          {
            "code" : "90630",
            "display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use"
          },
          {
            "code" : "90644",
            "display" : "Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"
          },
          {
            "code" : "90645",
            "display" : "Hemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for intramuscular use"
          },
          {
            "code" : "90646",
            "display" : "Hemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, intramuscular use"
          },
          {
            "code" : "90647",
            "display" : "Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use"
          },
          {
            "code" : "90648",
            "display" : "Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"
          },
          {
            "code" : "90653",
            "display" : "Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use"
          },
          {
            "code" : "90654",
            "display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use"
          },
          {
            "code" : "90655",
            "display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
          },
          {
            "code" : "90656",
            "display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
          },
          {
            "code" : "90657",
            "display" : "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
          },
          {
            "code" : "90658",
            "display" : "Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use"
          },
          {
            "code" : "90660",
            "display" : "Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use"
          },
          {
            "code" : "90661",
            "display" : "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
          },
          {
            "code" : "90662",
            "display" : "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
          },
          {
            "code" : "90672",
            "display" : "Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use"
          },
          {
            "code" : "90673",
            "display" : "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
          },
          {
            "code" : "90674",
            "display" : "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
          },
          {
            "code" : "90682",
            "display" : "Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
          },
          {
            "code" : "90685",
            "display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
          },
          {
            "code" : "90686",
            "display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
          },
          {
            "code" : "90687",
            "display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
          },
          {
            "code" : "90688",
            "display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
          },
          {
            "code" : "90689",
            "display" : "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
          },
          {
            "code" : "90694",
            "display" : "Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use"
          },
          {
            "code" : "90697",
            "display" : "Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"
          },
          {
            "code" : "90698",
            "display" : "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"
          },
          {
            "code" : "90721",
            "display" : "Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Hemophilus influenza B vaccine (DTaP/Hib), for intramuscular use"
          },
          {
            "code" : "90748",
            "display" : "Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"
          },
          {
            "code" : "90756",
            "display" : "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:6098df0b-6d94-49b2-8e2d-84335238fbb2",
    "timestamp" : "2024-12-10T08:47:22-05:00",
    "total" : 25,
    "contains" : [
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90644",
        "display" : "Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90647",
        "display" : "Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90648",
        "display" : "Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90653",
        "display" : "Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90655",
        "display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90656",
        "display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90657",
        "display" : "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90658",
        "display" : "Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90660",
        "display" : "Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90661",
        "display" : "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90662",
        "display" : "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90672",
        "display" : "Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90673",
        "display" : "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90674",
        "display" : "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90682",
        "display" : "Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90685",
        "display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90686",
        "display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90687",
        "display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90688",
        "display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90689",
        "display" : "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90694",
        "display" : "Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90697",
        "display" : "Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90698",
        "display" : "Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90748",
        "display" : "Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "90756",
        "display" : "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
      }
    ]
  },
  "text" : {
  }
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.